SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is facing significant downward pressure as investors weigh a sharp revaluation against the dilution concerns stemming from its all-stock acquisition of Synaptics. While some community members remain bullish on the long-term strategic potential of combining power, sensing, and edge AI technologies, current sentiment is dominated by volatility, structural skepticism, and active debate over whether this represents a long-term entry point or a period of prolonged consolidation.

T1 Energy, Inc. engages in providing energy solutions focused on solar module and solar cell manufacturing. It focuses on building an integrated U.S. supply chain for solar and batteries. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy Inc. (TE) is currently experiencing intense volatility amid a short-seller report and broader market pullbacks, with investors debating whether these dips represent a high-risk accumulation point or a structural breakdown. The community remains focused on the company's long-term potential as a U.S. solar infrastructure play and its ongoing Austin G2 facility ramp-up, while actively watching for signs of institutional support and a reversal from recent lows.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile US is currently at the center of widespread industry speculation regarding a potential acquisition or strategic partnership with SpaceX to integrate Starlink's satellite network into a full-scale global connectivity platform. While investors debate the technical feasibility and long-term M&A probability, the stock is also reacting to institutional accumulation and broader investor interest in telecom-satellite convergence as a hedge against industry-wide infrastructure challenges.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

The Health Care sector has seen a surge in investment interest as market participants rotate into defensive names, fueled by both record-breaking relative performance and ongoing discussions about sector-wide policy impacts. Traders are actively monitoring potential volatility stemming from Medicare Advantage rate uncertainty while focusing on selective outperformance in big pharma and medical devices.

Paysafe Ltd. provides online payment solutions. The firm operates through the following segments: Merchant Solutions and Digital Wallet. The Merchant Solutions business segment focuses on card not present and card present solutions for small to medium size business merchants. The Digital Wallet business segment provides wallet based online payment solutions through its Skrill, eCash solutions and NETELLER brands. The company was founded in 1996 and is headquartered in London, the United Kingdom.

Paysafe Limited

Paysafe Limited is currently polarizing investors as it navigates significant debt concerns and institutional selling, while proponents highlight a potential buyout valuation discount and new board expertise as catalysts for a turnaround. Community sentiment remains deeply divided between those viewing the ticker as a classic SPAC-era trap nearing bankruptcy and those betting on a rebound driven by its niche payments footprint.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending as investors speculate on the upcoming Goliath mainnet launch and look for a breakout from recent consolidation. The community remains sharply divided, with bulls pointing to the potential for institutional utility and long-term staking rewards, while bears caution against recurring pump-and-dump patterns and lack of transparent project updates.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is seeing significant market activity following the FDA's acceptance of its resubmitted BLA for RP1, paired with a positive upgrade from JPMorgan and a potential Advisory Committee meeting in late July. Investors are actively debating the likelihood of approval given the company's prior regulatory setbacks, with community sentiment split between optimism over a more receptive FDA and skepticism regarding the clinical data package.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is capturing significant community attention as institutional interest in tokenized assets and staking rewards drives a broader ecosystem narrative. Investors are actively discussing the network's ongoing real-world adoption, including bank integration trials, while maintaining a focus on accumulation strategies despite market volatility.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending following a favorable court ruling that remanded its legal dispute with Nippon Shinyaku back to state court, which investors view as a procedural victory for the company's bid to regain full commercial control of its DMD therapy. Community sentiment remains focused on the upcoming August PDUFA date and anticipation for the release of 5-year HOPE-2 OLE data, with many shareholders interpreting recent regulatory shifts in the biotech sector as a bullish catalyst for imminent FDA approval.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is facing significant volatility as investors digest both the Russell index rebalancing and shifting sentiment regarding data center power infrastructure. The community remains divided, with some market participants viewing the recent pullback as a prime buying opportunity for a long-term AI-play, while others express concerns over valuation and the potential for a deeper correction.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NutraLife BioSciences, Inc. engages in the development, manufacture and distribution of nutritional and dietary oral spray products. Its private label products include cannabidiol-infused oral sprays, tinctures, pet drops, pain balms and face creams and nutraceutical oral spray products for sleep support and weight loss packaged under the customer's brand names. The company was founded by Edgar Jason Ward on April 1, 2010 and is headquartered in Coconut Creek, FL.

NutraLife Biosciences Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

NLBSNutralife Biosciences Inc

Fundamentals

Latest NLBS News